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Abstract: Allergic asthma continues to represent a huge health burden worldwide and is 
largely treated by non-selective immunosuppressive drugs, which often prove ineffective. The 
hygiene hypothesis proposes that the increased incidence of allergy and asthma in Western 
countries observed in the last 50 years is due to environmental changes that include improved 
hygiene and a lack of infections. The immunological mechanisms that must underpin such an 
environmental impact on immune regulation remain to be deﬁ  ned, making it difﬁ  cult to iden-
tify speciﬁ  c ways of preventing development of allergy and asthma in early life. In this article 
we will seek to review some of the pathways that might underlie the hygiene hypothesis in an 
attempt to provide targets for future asthma prevention.
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The environment and asthma
Asthma is a chronic, inﬂ  ammatory disorder of the airways leading to airway remodeling. 
There are both genetic and environmental inﬂ  uences on asthma development, with 
sensitization to such factors as house dust mite and maternal smoking appearing to stem 
from as early as 22 weeks gestation. Most asthma is caused by an allergic response to 
innocuous antigens leading to Th2 cytokine release, eosinophilic inﬂ  ammation and 
IgE mediated mast cell degranulation. It is estimated that around 300 million people 
in the world currently have asthma, and the incidence has been rising dramatically. 
In 1989 Strachan postulated the hygiene hypothesis, in which he suggested that in 
the past allergy would have been prevented by early childhood infections but this 
protection had been diminished by changes in lifestyle over the past 30 years. Many 
aspects of modern living may contribute to this increase in asthma including, smaller 
family size, more urban living including a lower exposure to farm livestock, increasing 
vaccination and a more hygienic lifestyle.
Asthma is in most cases an allergic condition in which there is an immune response 
to innocuous environmental antigens leading to a Th2-type CD4 T cell response and an 
IgE antibody response. Both components are directly involved in the immunopathogen-
esis of asthma, the latter via triggering of mast cell inﬂ  ammatory mediators. Asthma 
is characterized by non-speciﬁ  c airway hyperresponsiveness and hyperreactivity to 
a range of usually innocuous stimuli such as cold air, mild infection, pollutants and 
even exercise, in addition to allergen exposure. There is chronic mucosal inﬂ  ammation 
(Beasley et al 1989) leading to damage to the lung epithelium, thickening of the sub-
basement membrane collagen layer, hyperplasia and hypertrophy of bronchial smooth 
muscle and hyperplasia of goblet cells leading to blockage of the bronchial lumen 
with mucus (Dunill 1960). It has long been accepted that there is a genetic component 
to the development of asthma and many studies have attempted to identify the genes 
involved. Of the many genes associated with asthma, the main chromosomes involved 
appear to be 5, 6, 11, 12 and 13. The region 5q31 of chromosome 5 contains genes for Biologics: Targets & Therapy 2007:1(2) 140
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the interleukins IL-4, IL-5 and IL-13. High level expression 
of these interleukins is classiﬁ  ed as a Th2 response, associ-
ated with atopy and asthma; polymorphisms in the IL-4 
and IL-13 genes are also associated with varying IgE levels 
(Marsh et al 1994; Wills-Karp et al 1998).
There is also an expanding list of environmental factors 
thought to be involved in the development of asthma. The 
most common allergens known to cause asthma are inhaled 
airborne particles which trigger a cascade of events leading 
to inﬂ  ammation and sensitization in the lungs. Exposure in 
early childhood to house dust mite (HDM) (Dermatophagoi-
des pteronyssinus) allergens is an important determinant of 
the subsequent development of asthma (Sporik et al 1990). 
Increasing sensitization correlates with increasing exposure 
to this and other allergens such as cockroach proteins in 
inner-city children (Rosenstreich et al 1997). Sensitization to 
HDM can occur from as early as 22 weeks gestation (Jones 
et al 1996), hence not only quantity of allergen is important 
as a trigger for asthma but also the timing of that exposure.
Another trigger may be lower respiratory tract virus 
infection in early life. Respiratory syncytial virus (RSV) is 
the most frequent cause of lower respiratory tract disease 
during infancy; although whether RSV bronchiolitis is a 
cause of later asthma development is unclear. RSV has been 
linked to recurrent wheeze but not atopic asthma in children 
up to age 13 (Stein et al 1999), but RSV bronchiolitis severe 
enough to cause hospitalization may indeed be linked to 
asthma (Sigurs et al 2000). Murine models have also linked 
airway inﬂ  ammation and hyperresponsiveness to acute RSV 
infection (Schwarze et al 1999), so it may be that severe, 
not mild RSV could damage the lungs and trigger asthma. 
Alternatively RSV symptoms may become severe because 
of sensitivity caused by the early stages of asthma.
As well as factors reported to cause asthma, a number are 
thought to exacerbate existing disease, including the presence 
and quantity of relevant allergens, cold air and exercise. Colds 
and respiratory viruses are thought to be responsible for 
80%–85% of asthma attacks (Johnston et al 1995). Passive 
smoking has been correlated with asthma severity and a higher 
risk of hospital admission for asthma (Eisner et al 2005). Air 
pollution has long been thought of as a cause of asthma but 
studies before German reuniﬁ  cation showed a lower preva-
lence of asthma in the more polluted East Germany (Nowak 
et al 1996), and New Zealand, with typically clean air has 
high levels of asthma (Beasley et al 1998).
It is therefore clear that there are both genetic and 
environmental inﬂ  uences on asthma development. Genetic 
polymorphisms may not cause asthma per se but predispose 
towards sensitization in particular environments. The critical 
events that determine whether allergy and asthma develop 
appear to occur in early childhood, up to around 3 years of 
age (Upham and Holt 2005), and may even be inﬂ  uenced 
in-utero (Skorge et al 2005). This provides a speciﬁ  c window 
of opportunity for asthma prevention.
The mechanisms of asthma
Asthma is an allergic response to an innocuous antigen, but 
how does that allergen trigger the initial immune response? 
The ﬁ  rst cells in the lung met by inhaled antigen are alveolar 
macrophages; in non-atopic individuals these cells are highly 
phagocytic, express strong microbicidal activity, are poor 
antigen presenting cells (APC) and are immunosuppressive. 
In asthmatics, these cells have reduced immunosuppressive 
function (Aubas et al 1984), increased APC function (Larche 
et al 1998), increased production of the Th2 cytokines IL-4 
and IL-5 (Tang et al 1998) and decreased production of IL-10 
(Borish et al 1996). Antigen missed by the alveolar macro-
phages is picked up by dendritic cells (DCs), and presented 
to naïve CD4+ T-cells. In healthy lungs mature pulmonary 
DCs produce IL-10 which induces T-cell tolerance (Akbari 
et al 2001), so diminished IL-10, as seen in asthmatics, may 
reduce antigenic tolerance. Activation of CD4 T-cells in the 
presence of certain cytokines polarizes the response towards 
Th1 or Th2. In the presence of IL-12 and IFN-γ Th1 cells 
are produced, whereas IL-4 induces cells to secrete Th2-type 
cytokines including IL-4, IL-5 and IL-13 (Del Prete et al 
1991). In the asthmatic, there is a lack of IL-12 produc-
tion from DC’s and allergen is thus presented to T-cells by 
DC’s and macrophages in a cytokine milieu that favors Th2 
development (van der Pouw Kraan et al 1997). Since respi-
ratory DC’s are immature in phenotype and poor producers 
of IL-12 (Stumbles et al 1998), and allergens lack pathogen 
associated molecules such as TLR ligands, which trigger 
IL-12 from DC’s (Schulz et al 2000), the immune response 
to inhaled allergens becomes abnormally skewed towards 
Th2 in the asthmatic (Robinson et al 1992).
B-cell activation by IL-4 directs isotype switching towards 
IgE. When produced by plasma cells, IgE binds to the high-
afﬁ  nity receptor FcεR1 on mast cells and basophils. When 
bound IgE is cross linked by antigen it causes rapid mast cell 
and basophil degranulation. The granules released contain 
histamine which promotes vascular permeability, smooth 
muscle contraction and mucus production, all symptoms of 
asthma. Cytokines released include IL-4, which feeds back 
onto B-cells, and IL-5, critical for eosinophil production and 
activation. Activated eosinophils release pro-inﬂ  ammatory Biologics: Targets & Therapy 2007:1(2) 141
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mediators and cytokines including more IL-5 and IL-13. 
IL-13 induces B-cell class switching to IgE and mast cell 
activation to give an inﬂ  ammatory response. Hence the 
production of Th2 cytokines acts in a positive feedback 
loop promoting IgE production and mast cell degranulation, 
increasing asthma symptom severity. Asthmatics have more 
activated Th2 cells in their bronchoalveolar lavage ﬂ  uid 
(Robinson et al 1992), and in murine models Th2 cells alone 
can recapitulate most key features of human asthma (Cohn 
et al 1998). However IgE levels are important as “asthma 
is almost always associated with some type of IgE-related 
reaction” (Burrows et al 1989) and severity is related to total 
serum IgE levels (Carroll et al 2006). Not only are there 
higher levels of IgE, but also increased numbers of mast cells 
in the airway smooth muscle of asthmatics (Brightling et al 
2002). In addition to immediate hypersensitivity reactions, 
this is likely to contribute to the airway remodeling events 
that are the consequence of chronic inﬂ  ammation (Yu et al 
2006).
As well as CD4+ Th2 cells, CD8+ Tc2 cells are thought 
to be involved in asthma, although less is known about their 
role. Respiratory DC’s cross-present allergen into the MHC 
Class I pathway, resulting in an allergen-speciﬁ  c CD8 T cell 
response (Wells et al 2007). Although CD8 T cells gener-
ally suppress allergy and are strongly biased towards Tc1 
development (Carter and Murphy 1999; Noble et al 2001), 
Tc2 cells with a cytokine proﬁ  le similar to that of Th2 cells 
can be induced in mice and humans. Allergen-speciﬁ  c Tc2 
cells inﬁ  ltrate the lung and recruit an eosinophilic inﬂ  am-
matory response with airway hyperreactivity (Sawicka et al 
2004). This may exacerbate the Th2 response and is likely to 
contribute to human asthma (Ying et al 1997). CD8+ T-cells 
inhibit IgE responses by favouring Th1 development and 
IL-12 and IL-18 secretion from DC’s (Thomas et al 2002; 
Salagianni et al 2007). Such cross-regulation between CD4 
and CD8 T cell populations may play a key role in immune 
regulation and development of respiratory tolerance.
Despite the dominant role of Th2 cells and IgE-mediated 
responses in the disease, other mechanisms have been impli-
cated, particularly in chronic asthma. Tumor necrosis factor-α 
(TNF-α, a Th1-associated cytokine, is present at high levels 
in the airways of chronic asthmatics, and its blockade can 
improve symptoms (Howarth et al 2005; Holgate and Polosa 
2006). Transforming growth factor-β (TGF-β) produced from 
a number of cell types contributes to the airway remodeling 
process through its pro-ﬁ  brotic functions (McMillan et al 
2005), as may the eosinophils present in the airway (Humbles 
et al 2004). IL-17 is also strongly upregulated in asthma 
(Hashimoto et al 2005), and may be involved in the neutrophil 
recruitment to the airways (Hellings et al 2003) which is more 
prominent in chronic disease. IL-17 is the hallmark cytokine 
of the newly described Th17 subset of T cells (Harrington 
et al 2005), but it is unknown whether these cells play an 
important role in airway inﬂ  ammation.
Asthma prevalence and importance
Asthma is one of the commonest chronic diseases of afﬂ  uent 
societies. It is estimated that around 300 million people in 
the world currently have asthma (Masoli et al 2004). The 
two largest international surveys of asthma prevalence and 
severity are the European Community Respiratory Health 
Survey (ECRHS) and the International Study of Asthma and 
Allergy in Childhood (ISAAC). ISAAC studied children aged 
between 13 and 14 years in 56 countries worldwide (Beasley 
et al 1998). They found the lowest asthma prevalence in 
Indonesia with 1.6%, and the highest in the UK, with 36.8% 
of children in the study reporting symptoms of asthma in the 
previous 12 months. They also found that countries report-
ing high asthma rates also reported high rates of allergic 
rhinoconjunctivitis and atopic eczema. This includes the UK, 
New Zealand, Australia, and the Republic of Ireland. Those 
with the lowest rates included Indonesia, several Eastern 
European countries, Greece, China and Taiwan. The ECHRS 
looked at asthma prevalence in 22 different countries and 
found similar results with the highest asthma rates in English 
speaking countries, and low rates in Mediterranean and 
Eastern European countries (Janson et al 2001). The results 
were similar for physician diagnosed asthma (Janson et al 
1997); New Zealand and Australia had the highest rates with 
11%–13% of the population sampled affected, with rates of 
anti-asthma medication use at 12%–16%. In the UK, 8.5% of 
the population are receiving treatment for asthma and 50% 
of these are experiencing severe asthma symptoms. One in 
six of these reported weekly attacks so severe they could not 
speak (Asthma UK 2003). In terms of healthcare costs the 
total US costs for asthma were estimated at $10.7 billion in 
1994 (Weiss et al 2000). The UK cost was £889 million in 
2003 (Asthma UK).
Asthma mortality rates also show large variations 
between countries, not only due to numbers and severity 
of cases but also access to prompt, specialist medical care. 
Countries with the highest asthma rates do not necessar-
ily have the highest mortality rates, for example the UK 
mortality rate is 2.9–3.2 per 100,000 asthmatics, the New 
Zealand rate is 4.6. Whereas Russia and China have low 
asthma prevalence, mortality rates are very high (28.6 and Biologics: Targets & Therapy 2007:1(2) 142
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36.7 fatalities per 100,000 asthmatics respectively (Masoli 
et al 2004)), underlining the fact that most asthma deaths 
are preventable. Nevertheless, even in the UK, asthma kills 
around 1400 people every year (Asthma UK 2003).
In addition to worldwide variation, it is clear that in the 
past 50 years the worldwide prevalence of not only asthma but 
other allergic diseases such as allergic rhinitis and eczema has 
increased dramatically. Hay fever was regarded as extremely 
rare until the 19th century (Emanuel 1988), when it was 
associated with the upper classes of society. Later increases 
in atopy and asthma have been well documented in the UK 
(Burr et al 1989; Kuehni et al 2001). In 8–13 year old children 
the incidence of asthma, hay fever and eczema more than 
doubled over a 25 year period (Ninan and Russell 1992), and 
there was a six-fold increase in asthma indicidence between 
1973 and 2003 (Burr et al 2006). In Scandinavian countries, 
similar increases have been observed. In Sweden, asthma, 
allergic rhinitis and eczema incidence roughly doubled be-
tween 1979 and 1991 (Aberg et al 1995), increases were also 
observed in Norway (Skjonsberg et al 1995), and in Finnish 
young men a 20 fold increase was reported between 1961 and 
1989 (Haahtela et al 1990). In more recent years this trend 
may be slowing down or even reversing. In Italy, Ronchetti 
et al (2001) found increases in asthma between 1974 and 1992 
but no further increases up to 1998. Similar results were seen 
in Switzerland and Germany (Braun-Fahrlander et al 2004; 
Zollner et al 2005). UK results are more confusing. Increases 
in wheeze and asthma attacks but a decrease in hospital admis-
sions have been reported, although this is probably a result of 
better asthma drugs and management (Butland et al 2006). 
Although the incidence of asthma might now be falling in 
Europe, elsewhere, as in Taiwan (Yan et al 2005), the trend 
still appears to be upwards. In less afﬂ  uent countries adopting 
an increasingly Westernized lifestyle, it appears that increasing 
asthma prevalence is an inevitable consequence, accompanied 
by much higher mortality rates.
Clearly the increase in asthma prevalence could not be 
caused by genetic factors as a change in the genetic pool 
would not occur in such a short period of time. Therefore, 
it must be caused by environmental factors. What are the 
changes in lifestyle that have been occurring in the last 
50 years since the second world war which could cause such 
an impact on disease?
The hygiene hypothesis
The hygiene hypothesis was ﬁ  rst postulated by Strachan in 
1989 (Strachan 1989). In his paper he notes that the increase 
in prevalence of asthma and childhood eczema reported by 
Emanuel (Emanuel 1988) and Fleming (Fleming and Crombie 
1987) could be due to several factors. He observed that the 
incidence of hay fever was inversely related to the number 
of children in the household when a child was aged 11, 
and that the trend was steeper when the siblings were older 
than the child. The incidence of eczema was also inversely 
related to the number of older, but not younger siblings. From 
this, Strachan concluded that in the past, allergic diseases 
could have been “prevented by infection in early childhood 
transmitted by unhygienic contact with older siblings” but 
this protection has been diminished over the past century by 
“declining family size, improvements in household ameni-
ties and higher standards of personal cleanliness”. A more 
recent study of individuals born pre 1980 concluded that 
low socio economic status at birth as well as increasing birth 
order was associated with a lower risk of allergy (Kinra et al 
2006). Over the years, this hypothesis has been revisited and 
expanded to include more atopic disorders and other features 
of modern living in an effort to elucidate the major cause or 
causes of the current asthma epidemic.
Some studies focused on the original issue of hygiene 
such as that by Zhang et al (2005) looking at the incidence 
of rhino-conjunctivitis, wheezing and asthma among 
school children in Western Australia, comparing asthma 
symptoms to household cleanliness. As with similar stud-
ies, this is based upon questionnaires ﬁ  lled in by families 
and relies on parental diagnosis of children’s symptoms 
and the family’s hygiene habits, both of which can be sub-
jective. Despite these drawbacks, this and similar papers 
show an inverse relationship between asthma and house 
cleanliness, although parents of a child with asthma are 
more likely to keep a clean house in order to reduce their 
child’s symptoms.
Other research has built on the idea that children born 
to large families are less likely to develop asthma, and 
suggested that interactions with other children at day-care 
centers can transmit infections in the same way as interac-
tions with siblings. Some researchers found no association 
between day-care attendance and development of atopic 
diseases (Backman et al 1984) whereas others found that 
day-care attendance did protect against allergies, but only 
for children from smaller families, or children who attended 
from a younger age (6–11 months) (Kramer et al 1999; 
Ball et al 2000). Another theory is that children in rural 
communities are protected from asthma because they interact 
with livestock from an early age. Yemaneberhan et al (1997) 
compared asthma rates in urban and rural Ethiopia. They 
found wheezing and asthma were more prevalent in urban Biologics: Targets & Therapy 2007:1(2) 143
Hygiene hypothesis and asthma
areas, this increase was related to housing style, bedding 
materials and use of certain insecticides. Comparisons have 
also been made in the USA (Adler et al 2005) with similar 
results; farm-reared children (up to the age of 5) were less 
likely to have a history of wheezing or develop asthma than 
their non farm-reared counterparts. Interestingly they report 
no difference in incidence between farm and non farm-reared 
children for non-asthma allergy, again suggesting subtle 
but important differences in the causes of asthma compared 
to other allergies. In rural communities in Europe, similar 
results were obtained. Allergic disease correlates negatively 
with the amount of exposure to livestock (Von Ehrenstein 
et al 2000). Since fewer families in Europe are involved in 
farming compared to 50 years ago, this may have contributed 
signiﬁ  cantly to the asthma increase.
Is exposure to domestic pets also a protective factor? 
Children reared in houses with high levels of pet allergen 
have sensitization to these allergens, which is strongly 
associated with asthma (Ingram et al 1995). On the other hand 
children exposed to pets in the ﬁ  rst year of life have a lower 
frequency of allergic rhinitis at 7–9 years and of asthma at 
12–13 years (Hesselmar et al 1999). Thus exposure to high 
doses of allergens early in life can induce operational toler-
ance which is long-lasting.
One common factor in these studies is the importance of 
childhood infections, whether from siblings, other children 
in day-care or farm livestock. Children are less likely to 
develop wheeze or asthma at age 7 if they have developed 
2 episodes of runny nose before the age of 1, or 1 viral 
infection of the herpes type in the ﬁ  rst 3 years of life (Illi 
et al 2001). Matricardi et al (1997) looked at hepatitis A 
seropositive and negative Italian men, prevalence of atopy 
and atopic respiratory diseases. They concluded that preva-
lence of atopy was lower amongst seropositive individuals; 
however, incidence of atopy amongst seronegative individu-
als was as low as that of seropositive individuals when they 
had three or more older siblings. Thus increases in asthma 
could be due to fewer childhood infections passed on by 
older siblings. Similar results show a lower prevalence of 
atopy amongst children who have had measles infection 
compared to those who have been vaccinated. Interestingly, 
the widely-used aluminium based adjuvants used in subunit 
vaccines have been shown to induce higher levels of IgE 
antibodies (Cogne et al 1985). Use of such vaccines rather 
than live/attenuated organisms may help skew the immune 
system towards a Th2 phenotype.
Another area of interest is that of mycobacterial infec-
tion, Shirakawa et al (1997) suggested that amongst Japanese 
schoolchildren there was a strong inverse association between 
delayed hypersensitivity to Mycobacterium tuberculosis and 
atopy, including asthma. Later studies in the Gambia (Ota 
et al 2003), and Australia (Marks et al 2003), largely failed 
to reproduce these ﬁ  ndings. In areas where there is a high 
prevalence of geohelminth infections such as Africa, the 
Eastern Mediterranean and South East Asia, there is a lower 
prevalence of asthma, despite the Th2-type response elicited 
by many of such infections. Indeed it was shown that there 
is a lower prevalence of allergic disease in patients infected 
by geohelminths (Catapani et al 1997) again indicating the 
protective effect of infectious organisms. Conversely, use 
of antibiotics in infants may be associated with asthma 
(Wickens et al 1999), alternatively antibiotic use may be 
more common in asthmatic children (Celedon et al 2004). 
Antibiotics disturb the composition of the gut microﬂ  ora, 
which is likely to be important for development of a robust 
immunoregulatory network.
These studies provide an increasing body of evidence 
demonstrating that the way we live today has a major impact 
on the health of our children. This increasingly “westernized” 
way of life, including smaller family size, lower exposure 
to farm animals, more urban living, and lower exposure to 
childhood diseases through increased hygiene awareness and 
vaccination, is apparently leading to increased incidence of 
not only asthma but other atopic disease including hay fever 
and eczema. So how important is allergen exposure versus 
hygiene or infection, and what are the immunological mecha-
nisms that might explain why this is happening?
Mechanisms of the hygiene hypothesis
Th1/Th2 dysregulation
Individuals who develop asthma have an imbalance in the 
Th1/Th2 cytokine response with a bias towards Th2 cytokine 
production (IL-4, IL-5 and IL-13). The hygiene hypothesis 
suggests that a reduction in childhood infections due to 
improved hygiene and smaller family size may alter the Th1/
Th2 cytokine balance, with insufﬁ  cient stimulation of Th1 
cytokine producing cells, giving an increasingly polarized 
Th2 response. Higher endotoxin concentrations have been 
found in farming rather than non farming households (von 
Mutius et al 2000). Endotoxin consists of lipopolysaccharide 
(LPS) which elicits Th1 responses through increased IL-12 
production (Macatonia et al 1995), although the protective 
effects of LPS are seen only at high doses (Piggott et al 
2005). Altering the cytokine balance in asthmatics towards 
a more Th1 like proﬁ  le is almost certainly beneﬁ  cial. In 
a murine model of asthma, IFN-γ administered during Biologics: Targets & Therapy 2007:1(2) 144
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either the primary sensitization or the secondary immune 
response decreased IgE production, prevented airway 
hyperresponsiveness and up-regulated Th1 cytokines (Lack 
et al 1996; Yoshida et al 2002). Unfortunately results of trials 
in human severe asthma were less impressive (Boguniewicz 
et al 1993). Transferring IFN-γ secreting Th1 cells into mice 
gives neutrophilic but not eosinophilic inﬂ  ammation char-
acteristic of an allergic response (Cohn et al 1998). Airway 
eosinophilia and hyperresponsiveness were abolished in mice 
by using recombinant IL-12 to enhance the Th1 response 
(Kips et al 1996). In humans, however, there was a decrease 
in eosinophil levels but no change in airway hyperrespon-
siveness (Bryan et al 2000); hence eosinophil levels are not 
necessarily an indicator of asthma.
If bacterial infections skew the cytokine response 
towards Th1, perhaps immunization with bacterial com-
ponents can elicit a similar response. Eisenbarth et al 
(2002) showed that low levels of inhaled LPS, signaling 
through TLR-4, induced Th2 responses in a mouse model 
of allergic sensitization but high LPS levels induced Th1 
like responses. Absence of LPS gave no signiﬁ  cant lung 
response, as there is no “danger signal” received by the 
DCs. In humans, high dose of exposure to endotoxins 
present in house dust mite is protective for allergy but 
this is dependent on genetic inﬂ  uences (Simpson et al 
2006). CpG DNA, a potent TLR9 ligand that induces 
IL-12 secretion and Th1 responses, prevents allergic airway 
inﬂ  ammation (Shirota et al 2000). Furthermore a number of 
studies (Zuany-Amorim et al 2002; Smit et al 2003) have 
shown that immunizing mice with Mycobacteria prevented 
allergic manifestations and suppressed features of asthma. 
Unfortunately human trials using M. vaccae (Shirtcliffe 
et al 2003) have not been successful.
Analogous to the Th1/Th2 cytokine imbalance in 
asthmatics there may also be a CD8+ Tc1/Tc2 imbalance. 
Indeed, Tc2 cells have been found in the lungs of asthmatics 
(Ying et al 1997), and as with CD4+ T cells, low antigen 
concentrations in vitro stimulate murine Tc2 development, 
but higher doses induce Tc1 cells (Sawicka et al 2004). 
Furthermore, Tc2 cells have been demonstrated to induce 
airway hyperresponsiveness and recruit eosinophils to the 
lungs (Sawicka et al 2004). These responses may amplify 
those of CD4+ T-cells. By contrast, Tc1 CD8 cells down-
regulate IgE by stimulating DCs to produce IL-12 and IL-18 
(Salagianni et al 2007), activate CD4+ Th1 cells to produce 
IFN-γ which inhibits IgE producing B-cells (Thomas et al 
2002), and inhibit allergic airway inﬂ  ammation (Wells 
et al 2007).
Teffector/Treg dysregulation
The theory of increased immune bias towards Th2 causing 
increased asthma has two major drawbacks. Firstly, areas 
with high levels of helminth infection are areas where 
asthma is less prevalent, so helminth infection appears to 
confer protection against asthma. However, worm infections 
such as schistosomiasis elicit a strong Th2 response (Araujo 
et al 1996). Secondly, autoimmune diseases such as Type-1 
diabetes and multiple sclerosis are also increasing in preva-
lence (Group 2000; Grytten et al 2006). These conditions 
are both characterized by Th1 or CD8 T cell inﬂ  ammation, 
indeed work has shown that individuals with type-1 diabetes 
(Douek et al 1999) and multiple sclerosis (Oro et al 1996) are 
much less likely to develop asthma. How can conditions that 
exhibit a Th1 bias be increasing in prevalence at the same 
time and in the same countries as those with a Th2 bias? 
A likely explanation is that immune dysregulation is appar-
ent in regulatory T cell populations, so instead of a balanced 
response to immune challenge leading to tolerance, the 
individual generates skewed Th1 or Th2 responses to 
autoantigens or allergens. Another possibility is that multiple 
sclerosis is mediated predominantly by Th17-type cells, 
rather than Th1 cells as previously thought (Weaver et al 
2006). Th17 cells might also be involved in asthma, since 
IL-17-producing cells are present in the airways of asthmatics 
(Molet et al 2001; Hashimoto et al 2005). Notably, both Th17 
and Th2 cell development are strongly inhibited by IFN-γ 
(Afkarian et al 2002; Harrington et al 2005). Thus, a lack of 
IFN-γ production early in an immune response to allergen 
might lead to dysregulated Th2 or Th17 responses.
There is growing interest in the function of regulatory 
T-cells (Tregs) in relation to asthma (Figure 1). There are 
several types of Treg, broadly characterized into naturally 
occurring (thymically derived), which are CD4+CD25+FoxP3+ 
(Sakaguchi 2004), and inducible, CD4+ (Hawrylowicz and 
O’Garra 2005) or CD8+ (Noble et al 2006) Treg. Naïve 
T-cells stimulated in the presence of IL-10, or treated with 
glucocorticoids and vitamin D3, mature into IL-10 producing 
regulatory Tr1 cells (Groux et al 1997; Barrat et al 2002) that 
suppress CD4+ T-cell proliferation in response to antigen. 
IL-10 inhibits dendritic cell function and release of histamine 
from activated mast cells (De Smedt et al 1997; Royer et al 
2001). In allergic individuals, allergen-speciﬁ  c CD4 cells se-
crete less IL-10 and more IL-4 than normal individuals, which 
produce Tr1-like cells in response to allergens (Akdis et al 
2004). Additional subsets of induced Treg include those that 
express FoxP3 after exposure to TGF-β (Chen et al 2003), 
and CD8+, cytokine-induced Treg (Noble et al 2006). These Biologics: Targets & Therapy 2007:1(2) 145
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can elaborate additional suppressive pathways dependent on 
cell contact and/or TGF-β (Zheng et al 2004).
How increased hygiene might modify Treg function 
is unclear. Suppression by Tregs is blocked by microbial 
activation of Toll-like receptor pathways in DCs (Pasare and 
Medzhitov 2003). Therefore, induction and maintenance of 
Treg populations is most likely to be at fault during the ear-
lier stages of the disease. Ling et al found a signiﬁ  cant reduc-
tion in the ability of naturally occurring CD4+CD25+ Tregs 
from atopic compared to non-atopic donors, to suppress 
allergen-stimulated CD4+CD25- T-cell proliferation and 
IL-5 production in vitro (Ling et al 2004). The ability to 
suppress was even more reduced in individuals with active 
hay fever. Treg function was also found to be reduced in a 
number of other autoimmune conditions such as diabetes 
(Kukreja et al 2002). This is evidence of a role for these 
cells in disease etiology, but could simply reﬂ  ect the fact 
that activated effector T cells are less susceptible to suppres-
sion (Liu et al 2006). However, recent data demonstrating 
that Foxp3+ cells are induced by infection and are present at 
inﬂ  ammatory sites (Wilson et al 2005; Baumgart et al 2006), 
support the idea that a lack of microbial exposure could 
prevent the development of a robust regulatory network 
of Treg populations. In addition, certain infectious agents 
appear capable of inducing a Tr1-type response through 
altering the balance of IL-10 and IL-12 secretion from DC 
(McGuirk et al 2002).
It seems likely that the natural gut microﬂ  ora have 
a major inﬂ  uence over immunoregulatory functions, in 
addition to the impact of pathogenic infection. The gut 
contains over 1013 microbes which collectively express 
100 times as many genes as the human genome (Gill et al 
2006). This provides, along with food, an enormous range 
of foreign antigens with which the innate and acquired 
mucosal immune system interact. Diet, smoking and an-
tibiotics all alter the microﬂ  ora composition (Adamsson 
et al 1997). Differences have been observed between the 
microﬂ  ora in infants who do and do not go on to develop 
asthma. Infants who develop asthma are more likely to 
have fewer aerobic bacteria (eg, Lactobacilli) and Biﬁ  do-
bacteria but more Clostridia and Staphylococci (Bjorksten 
et al 2001; Kalliomaki et al 2001), although this may be a 
symptom rather than a cause. Sudo et al showed that without 
Biﬁ  dobacterium in the microﬂ  ora, germ-free mice showed 
increased IgE and IL-4 production and no oral tolerance 
(Sudo et al 1997). Oral tolerance, in addition to preventing 
food allergy, can suppress asthmatic responses in the lung 
(Russo et al 2001). Other than antibiotic use or more ster-
ile food production, it is not clear how improved hygiene 
affects the microﬂ  ora balance. Breastfeeding may inﬂ  uence 
the early microﬂ  ora composition as well as inducing oral 
tolerance in the child to antigens taken up by the mother.
Interplay of innate responses with acquired immunity 
and memory populations
The immune response to a newly encountered allergen can be 
inﬂ  uenced by a diverse array of innate immune mechanisms. 
Natural killer (NK) cells, NKT cells and γδ T cells are potent 
Figure 1 Regulatory networks that could be dysregulated in a hygienic environment. T cell development in the presence (left) or absence (right) of TGF-β is shown sepa-
rately for clarity.  The degree of shading represents the level of danger in the environment. FHA, ﬁ  lamentous hemagglutinin of Bordetella pertussis (McGuirk et al 2002); BLP, 
bacterial lipoprotein (Liu et al 2006).
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sources of IFN-γ early in the immune response (Hiromatsu 
et al 1992; Cui et al 1999; Martin-Fontecha et al 2004). 
This is critical for Th1 development, and thus suppression 
of Th2 responses, through activation of STAT-1 signaling, 
which upregulates Tbet expression (Afkarian et al 2002). 
The presence of microbes and associated Toll-like receptor 
(TLR) ligands during exposure to allergens is therefore likely 
to increase the availability of early IFN-γ, and prevent Th2 
skewing. Likewise, the presence of viral RNA triggers strong 
IFN-α production in DCs which enhances IL-12 production 
and Th1 development (Farrar et al 2000; Van Uden et al 
2001). Conversely, innate cells including mast cells, NKT 
cells and eosinophils can secrete IL-4 which would favour 
Th2 development. In several experimental models the pres-
ence of an infection suppresses allergic airway inﬂ  ammation 
(Hansen et al 2000; Koh et al 2001; Wohlleben et al 2003). 
While these pathways might explain short term effects of 
microbial load on allergic sensitization, it cannot explain 
the long-term effects that are an essential component of the 
hygiene hypothesis. For example, Asians migrating to the 
UK from India up to the age of 4 are protected from asthma 
in adulthood, while those migrating later are not (Kuehni 
et al 2007). How can such early infection have such a lasting 
impact on the immune response to allergens not encountered 
until decades later? While innate immune cells may be 
involved, these are relatively short lived and innate cells, 
by deﬁ  nition, do not mediate immunological memory. It is 
therefore reasonable to predict that there is a link between 
the mechanisms behind the hygiene hypothesis and those of 
immunological memory.
The T cell compartment is thought to mediate the most 
long-term components of immune memory. In experimental 
models, it has been shown that CD8 memory T cell popula-
tions are extremely long-lived (Murali-Krishna et al 1999). 
Although individual memory T cells are not immortalized, 
antigen-speciﬁ  c CD8 populations are maintained through 
homeostatic proliferation in response to IL-15 and IL-7 
(Zhang et al 1998). Crucially, this mechanism ensures that 
no antigen is required, so these populations can be retained 
indeﬁ  nitely even if the infection is not present (Murali-
Krishna et al 1999). Alternatively, the actions of regulatory 
T cells may prevent the total elimination of certain infec-
tions (Belkaid et al 2002) allowing subclinical, chronic 
infections to be established. This would provide continual, 
low level immune stimulation. Thus one can imagine that 
each infection encountered early in childhood might have 
a long-lasting impact on the immune system, resulting in 
an accumulation of mature memory cells. Although the 
proportion of circulating T cells with a memory phenotype 
does not increase dramatically with age due to separate 
homeostatic control of the naïve and memory pools (Lanza-
vecchia and Sallusto 2005), the nature of the memory pool 
could alter with age in response to environmental stimuli. 
This is probably also true of the Treg population (Akbar et al 
2007). The production of early cytokine such as IFN-γ from 
memory CD8 T cells could thus increase in early life without 
changes in the proportion of memory cells. But how could 
such alterations prevent allergic sensitization?
Since large clonal expansions of CD8 Tc1 cells are rap-
idly induced by viral and other intracellular infections, is it 
easy to speculate that CD8 T cell populations are involved 
in transducing the signals induced by infection into those 
that might prevent allergic disease. CD8 memory cells are 
likely to prevent allergic sensitization through their ability 
to rapidly secrete IFN-γ and activate DCs (Das et al 2001; 
Kambayashi et al 2003; Noble et al 2003). Mature CD8 
memory populations, induced by infection might therefore 
prevent Th2 responses to allergen through cross-reactivity, 
amplifying the Th1 arm of the response.
Alternatively, Treg populations primed by infection, 
rather than being derived from thymic selection as at birth, 
may accumulate in a “dirty” environment. These Treg may 
be more potently suppressive and act in a cross-reactive or 
non-speciﬁ  c fashion to inhibit responses to allergens. It is 
interesting to note that induction of IL-10-producing Tregs, 
which are more likely to be peripherally induced, is deﬁ  -
cient in severe asthmatics (Xystrakis et al 2006). The IL-10 
secretion can be improved by oral supplementation with 
vitamin D (Xystrakis et al 2006), the active form of which 
synergizes with glucocorticoids to induce Treg (Barrat et al 
2002). Another reason to implicate involvement of IL-10 
in the hygiene hypothesis is that it can be produced by both 
Th1 and Th2 cells, in addition to Treg and DCs (Trinchieri 
2001; Shoemaker et al 2006). Therefore the Th2 responses 
induced by helminths would invoke potent IL-10 secretion, 
perhaps leading to more robust Treg populations. IL-12 
induces IL-10 Treg in both CD4 and CD8 T cells (Gerosa 
et al 1996; Stock et al 2004; Noble et al 2006). Thus, Th1 
and Treg development may be linked, and the concurrent rise 
in allergy and autoimmunity could be explained by a lack 
of the negative feedback loop that involves IL-10-mediated 
suppression.
Are Treg induced by cytokines alone, or could they 
respond directly to pathogen associated molecules? Foxp3 
Treg express distinct patterns of TLRs compared to effector 
T cells (Sutmuller et al 2006), and their response to infectious Biologics: Targets & Therapy 2007:1(2) 147
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agents and cytokines is far from clear. A recent study showed 
that a TLR2 agonist could expand Foxp3+ Treg in vivo, and 
these retained their suppressive capacity after proliferation 
(Liu et al 2006). Strategies are therefore starting to emerge for 
therapeutic enhancement of Treg in vivo, which unlike Treg 
cellular therapies will be applicable to asthma treatment.
Conclusions and therapeutic 
implications
Clearly the immunological mechanisms involved in the 
hygiene hypothesis are far from clear and a lot more research 
is needed. This is currently an interesting time in which 
research on the hygiene hypothesis is moving from epide-
miological observations that support (or not) the theory, to 
more mechanistic studies and hypotheses. Will this emerging 
knowledge result in a reversal in the upward trend in asthma, 
or widespread use of novel therapeutics? Attempts to use 
Th1 cytokine inducing microbes to bias the response back to 
Th1 have thus far failed in humans, probably because such 
exposure is required in early life. The arguments against 
the theory of cytokine bias include the lower prevalence 
of asthma in areas with a high geohelminth burden and the 
increase in Th1 type autoimmune diseases in areas experi-
encing increases in Th2-mediated asthma. In the past there 
would have been exposure to higher antigen levels during 
gestation and the ﬁ  rst year of life due to more time being 
spent outdoors with a more rural lifestyle. Early infections 
and endotoxin exposure in such an environment are also 
protective. Could we mimick these conditions to prevent or 
treat asthma in children?
It could be that small changes to our environment in early 
life to maintain a healthy gut microﬂ  ora would reverse the 
trend of increasing asthma prevalence. However given the 
complexity of our environment and the scale of the problem, 
it is more likely that one factor alone will not reduce asthma. 
Instead, it may be necessary to introduce modiﬁ  cations to 
existing vaccines which ensure more robust development 
of childhood immunity, not just to the speciﬁ  c infection but 
in a non-speciﬁ  c fashion in order to prevent allergy. More 
understanding of the critical mechanisms is needed for this, 
but clearly TLR agonists are a likely component of such 
approaches – these include CpG DNA (TLR9), Pam3Cys 
(TLR1/2), monophosphoryl lipid A (TLR4) and poly I:C 
(TLR3), agonists, which activate DC and enhance IL-12 secre-
tion. Some of these have been tested in humans, and do not 
induce the side-effects associated with traditional adjuvants 
such as complete Freund’s adjuvant. Inclusion of this new 
generation of molecular adjuvants in vaccines might not only 
enhance the effectiveness of the vaccines themselves, but have 
a non-speciﬁ  c suppressive effect on allergic sensitization.
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